ATROPINE SULFATE - atropine sulfate injection, solution 
Covetrus North America

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

ATROPINE SULFATE Injections

(0.54 mg/mL)

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

INDICATIONS

For use in Dogs and Cats as an antidote in the treatment of organophosphate insecticide poisoning; to reduce salivation, bronchial secretions or intestinal peristalsis associated with colic or diarrhea, and as a preanesthetic adjuvant.

DOSAGE AND ADMINISTRATION:

Dogs and Cats:  Inject intravenously, intramuscularly, or subcutaneously, 1 mL for each 20 lbs of body weight as a preanesthetic adjuvant, or to reudce salivation, bronchial secretions, or intestinal peristalsis associated with colic or diarrhea. 

As an antidote for parasympathomimetic drugs, inject 1 mL for each 5 lbs of body weight administered to effect and repeat as necessary.  It is suggested that 1/4 of the dosage be injected intravenously and the remainder intramuscularly or subcutaneously.

WARNING

Poisonous alkaloid.

Antidotes:  Warmth, emetics, cholinergics

COMPOSITION

Each mL of sterile solution contains:

Atropine Sulfate  ............................  0.54 mg
Sodium Chloride .................................  9 mg
Benzyl Alcohol  ..................................  1.5%
Water for Injection  ................................  QS

Store at controlled room temperature between 15o and 30oC (59o-86oF)

PROTECT FROM LIGHT

TAKE TIME OBSERVE LABEL DIRECTIONS

CovetrusaAtropine Sulfate SA labelCovetrusaAtropine Sulfate SA label

ATROPINE SULFATE  
atropine sulfate injection, solution
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:11695-7000
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ATROPINE SULFATE (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) ATROPINE SULFATE0.54 mg  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11695-7000-1100 mL in 1 VIAL
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/01/2021
Labeler - Covetrus North America (603750329)

Revised: 7/2021
Document Id: ec396524-6be6-4fdd-873f-c1db1e2f0ae3
Set id: 083cab01-5c45-4ba6-b853-a00084686a8e
Version: 1
Effective Time: 20210701
 
Covetrus North America